Acibadem Saglik Hizmetleri ve Tic. A.S. (Acibadem Saglik) is the holding company of the Group and is listed on the Istanbul Stock Exchange with 35.15% free float. Mr. Mehmet Ali Aydinlar, Acibadem’s President and CEO, holds 34.99% of the total shares capital of Acibadem Saglik and other 26 individual shareholders holds the remaining 29.86%.

Total project cost is estimated at around $100 million. The proposed IFC investment is a loan of up to $40 million equivalent for IFC’s own account.

40.0 million (USD)

Product Line	IFC Investment (million USD)
Risk Management
Guarantee
Loan	40.0
Equity

* These investment figures are indicative

The location of two new hospitals in Istanbul will be at Maslak and Fulya district of Istanbul. The new hospital in Izmir is to be located at downtown Izmir.

The Expansion of Acibadem will have a strong development impact by expanding access to high quality healthcare in Istanbul and other cities of Turkey and demonstrating best administrative and patient care practices through out the medical community. In addition, Acibadem, has extensive public health and education programs, which are offered free of charge to the community.

IFC’s main role in the project is as a provider of flexible, tailored long-term financing on reasonable terms, which is currently not available to the private healthcare sector in Turkey.

This is a Category B project according to IFC’s Procedure for Environmental and Social Review of Projects because a limited number of specific environmental and social impacts may result which can be avoided or mitigated by adhering to generally recognized performance standards, guidelines or design criteria. The review of this project consisted of appraising technical, environmental, health and safety, as well as social/community information submitted by the project sponsor as well as a site visit to the construction site of their Acibadem’s new Bursa Hospital.

The following potential environment, health and safety (EHS), and social/community impacts of the projects were analyzed:

- Development and implementation of corporate EHS management systems by Acibadem;
(ii) Compliance of Acibadem’s existing and new facilities with Turkish and IFC EHS requirements;
(iii) Commitment of Acibadem to quality and efficiency and to EHS performance including international certification; and
(iv) Acibadem’s commitment to be a responsible corporate citizen.

Accordingly, IFC concludes that the proposed project will meet the applicable Turkish and IFC environment and social policies and the environmental, health and safety guidelines upon successful implementation of the agreed mitigation measures.
Location of environmental documents In locally affected community
The translated ERS will be available upon request, at Acibadem’s headquarters in Istanbul (Fahrettin Kerim Gokay Cad. 49,
Altunizade 34462 Istanbul, Turkey), Acibadem Bakirkoy Hospital (Halit Ziya Usakligil Sok. No:1 Bakirkoy, Istanbul, Turkey), Acibadem Kozyatagi Hospital (Inonu Cad. Okul Sok. No:20 Kozyatagi, Istanbul, Turkey) and Acibadem Kadikoy Hospital (Acibadem Cad. Tekin Sok. No:8 Kadikoy Istanbul, Turkey). It will also be published on the company’s website (www.acibadem.com.tr). An advertisement in a local newspaper will inform the local community of the availability of the ERS.